Insider Transactions in Q2 2022 at Diffusion Pharmaceuticals Inc. (DFFN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2022
|
Jane H Hollingsworth Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67
-8.0%
|
-
|
|
May 31
2022
|
Jane H Hollingsworth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
183
+17.92%
|
-
|
|
May 02
2022
|
Robert Joseph Cobuzzi Jr. Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
121
-10.81%
|
-
|
|
May 02
2022
|
Robert Joseph Cobuzzi Jr. Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
327
+22.61%
|
-
|
|
Apr 18
2022
|
William Robert Elder CFO & GC |
BUY
Conversion of derivative security
|
Direct |
100
+20.0%
|
$2,500
$25.0 P/Share
|
|
Apr 18
2022
|
Robert Joseph Cobuzzi Jr. Chief Operating Officer |
BUY
Conversion of derivative security
|
Direct |
100
+11.21%
|
$2,500
$25.0 P/Share
|